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Abstract 
Chemical synthesis and biochemical analysis of modified agonist peptides of the human thrombin receptor derived from the sequence SFLLRNP 
containing photoactivatable azido groups and biotin for sensitive detection is described. Substitution of leucine in position three with p-azidophen- 
ylalanine and extension of the C-terminus with a KGGK spacer containing biotin covalently linked to the side chain of the C-terminal ysine residue 
resulted in an active receptor agonist as determined by intracellular Ca” mobilization in human erythroleukemia (HEL) cells. In contrast, substitution 
of phenylalanine in position two with p-azidophenylalanine r duced agonist activity significantly. 
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1. Introduction 
ol-Thrombin, a serine protease, plays a key role in the 
coagulation cascade and acts as a growth factor for a 
number of different cell types [l-3]. Thrombin is thus 
essential to hemostasis, wound healing and tissue repair. 
Furthermore, thrombin might also be implicated in 
tumor vascularization and in the formation of athero- 
sclerotic plaques [4]. Inhibition of thrombin will affect all 
of these diverse activities and it would be advantageous 
in disease states where the growth factor activity of 
thrombin is involved, such as atherosclerosis, to block 
the respective receptor instead of inhibiting thrombin 
itself. 
Expression of mRNA derived from both human and 
hamster cDNA in Xenopus oocytes has led to the identi- 
fication of a functional thrombin receptor which is a 
member of the G-protein coupled receptor family con- 
taining seven membrane spanning domains [5,6]. Previ- 
ous work has shown activation to occur through prote- 
olytic cleavage by a-thrombin between residues R4’ and 
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Abbreviations: HEL, human erythroleukemia; Fmoc, W-9-fluoren- 
ylmethyloxycarbonyl; Boc, W-tert-butyloxycarbonyl; RP-HPLC, re- 
verse-phase high-performance liquid chromatography; ESMS, electro- 
spray mass spectrometry; BSA, bovine serum albumin; PBS, phos- 
phate- buffered saline; ELISA, enzyme-linked immunosorbent assay; 
HEPES, (N-[2-hydroxyethyllpiperazine-K-[2-ethanesulf onicacid]). 
S4’ in the extracellular N-terminal region of the human 
receptor, thus generating a new amino-terminus which 
functions as the activating ligand [5,7]. Interestingly, it 
was also shown that short synthetic peptides correspond- 
ing to the newly generated N-terminus were effective in 
activating the receptor, and structure-activity relation- 
ships using synthetic peptides have subsequently shown 
certain residues to be critical for receptor activation 
[8-141 (Table 1). 
Based on these results, we have synthesized two bioti- 
nylated peptide agonists containing photoactivatable 
groups as molecular tools to elucidate further the ligand 
binding site within the thrombin receptor. In the present 
paper, we describe the synthesis and analysis of two 
biotinylated p-azidophenylalanine-containing peptide li- 
gands and report on their biological activities in a human 
erythroleukemia (HEL) cell line, which has previously 
been shown to respond to both thrombin and thrombin 
receptor agonist peptides with an increase in intracellular 
Ca2+ concentration [151. 
2. Experimental 
2.1. Synthesis and purification of biotinylatedphotoactivatable peptides 
The biotinylated photoactivatable peptides were manually synthe- 
sized using standard W-tert-butyloxycarbonyl (Boc) chemistry on a 
methylbenzhydrylamine resin (0.2 mmol) as solid support [16], resulting 
in the respective C-terminal amides of the synthesized peptides. All 
chemicals used in the peptide synthesis were purchased from Peninsula 
Lab. Inc. (Belmont, CA, USA). A fourfold excess of Boc amino acids 
was used in each cycle of coupling. Boc-(N”-Fmoc)-lysine was the first 
amino acid attached to the resin and Boc-p-azidophenylalanine, which 
was prepared according to Schwyzer and Caviezel [17], was used for 
residues 2 and 3 of peptides AZO-I and AZO-2, respectively. After the 
last cycle of coupling (Boc-Serine (0-benzyl)) was completed, peptide 
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resins were treated with piperidine to remove the Fmoc-protecting 
group from the C-terminal lysine residue. Peptides were subsequently 
biotinylated with the N-hydroxysuccinimide ester of biotin (Pierce, 
Rockford, IL, USA). Both peptides were cleaved from the resin using 
anhydrous HF in the presence of 10% anisole and collected by ethyl 
ether precipitation. Peptides were purified by reverse-phase high-per- 
formance liquid chromatography (RP-HPLC) on a semi-preparative 
Vydac C, column (The Separations Group, Hesperia, CA, USA) using 
a 040% acetonitrile gradient in 0.1% trifluoroacetic acid developed 
over 40 min at a flow rate of 2 ml/min. 
2.2. Analysis of biotinylated photoactivatable peptides 
Amino acid composition analysis was performed by hydrolysis in 
6 N HCI followed by derivatisation to phenylthiocarbamyl amino acids 
using a model 420H analysis system coupled to an on-line model 130A 
HPLC (Applied Biosystems, Foster City, CA). Data acquisition and 
analyses of the chromatographic data were performed on a model 920A 
data acquisition system (Applied Biosystems) with norleucine as the 
internal standard. 
Electrospray mass spectrometry (ESMS) was performed on a triple 
quadrupole mass spectrometer with a mass range of 4000 equipped with 
a pneumatically assisted electrospray source (Fisons Bio-Q, VG-Bio- 
Tech, Altrincham, UK). Samples were dissolved in a mixture of water/ 
methanol (50 : 50) containing I % acetic acid at a concentration of 15-20 
pmol@l and 10 ~1 of this solution were introduced at a flow rate of 
4 @min into the ion source. Calibration was performed based on the 
multiply charged ions from a separate introduction of horse heart 
myoglobin (16951.5 Da), at a resolution so that the m/z = 998 peak was 
1.2 amu wide at 50% peak height. Scanning was performed from 
m/z = 350 to 1550 amu in I2 s in the multi-channel acquisition mode. 
2.3. Photolabelling 
To evaluate the capacity of the biotinylated photoactivatable pep- 
tides to crosslink with proteins upon photolysis, bovine serum albumin 
(BSA) was used as a model. BSA (10 mg/ml) was mixed with individual 
peptides AZO-1 and AZO-2 (2 mg/ml) in phosphate-buffered saline 
(150 mM NaCI, IO mM K,HPO,, pH 7.4; PBS) at room temperature 
for 1 h under N, gas. Half of the mixtures were stored at 4°C 
as controls. The photolysis tubes containing the other half of the 
BSA/peptide mixtures were irradiated at 4°C for 30 min using 4 RPR 
300 nm and 4 RPR 350 nm lamps. The photolyzed material was re- 
moved from the photolysis tubes and analyzed for BSA-peptide conju- 
gates by ELISA (see below). 
2.4. Enzyme-linked immunosorbant assay (ELISA) 
Aliquots of the photolyzed mixtures (BSA/AZO-I and BSA/AZO-2 
each equivalent to 200 ng of peptide) or 200 ng of AZO-I or AZO-2 
were coated onto microtiter wells of a 96-well ELISA plate (Nunc- 
Immunoplate, Nunc, Denmark) in 50 ~1 coating buffer (15 mM 
Table 1 
Consensus sequence of the human thrombin receptor agonist peptide 
NH, Ser’ Phe* LeuS Leu4 Arg’ 
Ala p-fluoro- Phe* Phe Gln 
Phe 
Met Trp Ile Lys 
Thr Tyr Ornithine 
Cys Ala Citruline 
Gly Be 
Isoserine Arg 
Gly 
Pro 
NH, Se+ 
NH, Ser’ 
AzidoPhe’ Leu’ Leu4 
Phe’ AzidoPhe’ Leu4 
Arg5 
Arg’ 
Asn6 
Asn6 
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Na,CO,, 35 mM NaHCO,, pH 9.6) for 16 h at room temperature. The 
plates were subsequently blocked with 0.1% (w/v) BSA in PBS for 30 
min. Serially diluted streptavidin-peroxidase solutions (Jackson Im- 
munoResearch Labs Inc., PA, USA) were added to the wells and 
incubated for I h at room temperature. After removal of the strep- 
tavidin-peroxidase conjugate, plates were washed five times with PBS 
containing 0.1% (w/v) Tween-20 and 0.1% (w/v) BSA. The plates were 
developed using tetramethylbenzidine in H,OI as a substrate and the 
reaction was stopped by addition of I N H,SO+ Absorbance was read 
at 450 nm using a Titretek Multiskan II (Flow Labs, VI, USA). Assays 
were performed in triplicate. 
2.5. Measurement of thrombin receptor agonist activity 
HEL cells were obtained from American Type Culture Collection 
(ATCC, Rockville, MD, USA) and maintained in RPM1 medium sup- 
plemented with 10% fetal calf serum. For measurement of thrombin 
receptor agonist activity, HEL cells were harvested and washed twice 
in RPM1 medium containing 10 mM HEPES, pH 7.3, and resuspended 
at 37°C in the same buffer at 5 x lo6 cells per ml. Fura-2/acetoxymethyl 
ester (Molecular Probes Inc., Eugene, OR, USA) was added to a final 
concentration of 4pM and the cells were incubated for 1 h at 37°C with 
gentle shaking. Cells were washed twice and resuspended at IO6 cells per 
ml in HEPESlsaline (10 mM HEPES, pH 7.3, 137 mM NaCI, 5 mM 
KCI, I mM Na,HPO,, 5 mM glucose, 1 mM CaCI,, 0.5 mM MgCI, and 
0.1% BSA). Two I ml aliquots were transferred into a quartz cuvette 
equipped with a magnetic stirrer which was placed in a thermostatically 
controlled chamber at 37°C in a PTI Delta-Scan-l fluorescence spectro- 
photometer (Photon Technology International Inc., Princeton, NJ, 
USA). Peptides were added directly at the indicated times to a final 
concentration of IO PM. During the experiments, the excitation wave- 
lengths were altered between 340 and 380 nm and fluorescence was 
measured by recording the emitted light at 510 nm. Bandwidths were 
4 nm on both excitation and emission monochromators. 
3. Results 
3.1. Design of peptides 
Since the discovery of the human thrombin receptor 
[5] and its hamster analog [6] a number of studies have 
focused on the structural requirements that lead to acti- 
vation of the receptor by the newly liberated N-terminus 
after thrombin cleavage. A compilation of the obtained 
results is given in Table 1 showing that positions 2 and 
4 allow only conservative changes while positions 1, 3 
Pro’ 
Pro’ 
Lys8 Gly9 Gly”’ BiotinLys CONH, (AZO-I) 
Lys8 Gly9 Gly1° BiotinLys CONH, (AZO-2) 
The natural sequence is given at the top with substitutions that do not affect activity significantly being listed below the respective amino acid residue. 
Sequences of the photoactivatable biotinylated peptides AZO-1 and AZO-2 are shown at the bottom. 
*Phe is the naturally occuring amino acid in the hamster, rat and mouse thrombin receptor. 
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Fig. 1. Electrospray mass spectra of peptides AZO-2 (A) and AZO-1 (B). Singly and multiply protonated molecular ions are labelled as [M+nH+]“+. 
Measured molecular masses (AZO-2, 1489.9 f 0.1 Da; AZO-1, 1455.7 f 0.1 Da) were calculated based on a series of three molecular ions (n: 1, 2 
and 3) and are given with their respective standard deviations. Signals at 1512.9 and 756.9 amu for AZO-2 (A) and 1478.9 for AZO-1 (B) relate most 
likely to Na’-adducts of the respective peptides. Ions at 1376.5 amu and 1342.5 amu for AZO-2 and AZO-I, respectively, may correspond to deletion 
of Asn during synthesis (measured Am = 114.4 Da [AZO-21; 114.2 Da [AZO-I]; expected Am = 114.1 Da). Furthermore, ions at 568.7 amu (doubly 
protonated) and 1136.6 amu (singly protonated) in the preparation of AZO-2 (measured mass: 1135.5 Da) may correspond to a missing biotinylated 
lysine (measured Am = 354.4 Da; expected Am = 354.5 Da). The contaminant with a measured mass of 1327.6 Da (singly and doubly protonated ions 
at 1328.6 and 664.8 amu, respectively) could not be correlated with simple truncations or deletions of AZO-2. 
and 5 are more tolerant. Furthermore, a free N-terminal 
amino group appears to be important for activity. These 
results led us to design two photoactivatable peptides 
with substitutions in positions 2 (AZO-1) and 3 (AZO-2) 
with the aim of further probing the structural require- 
ments for receptor activation as well as to develop molec- 
ular tools to be used in studying the architecture of the 
ligand binding site within the receptor. In addition, a 
biotin moiety was included in each peptide to allow easy 
and sensitive detection of the photocrosslinked peptides 
as well as to potentially serve as affinity handles for 
receptor purification. The biotin label was attached to a 
C-terminal KGGK extension of the agonist peptide, thus 
providing a spacer which should facilitate detection by 
streptavidin since extensions of the C-terminal part of 
the originally described agonist peptide SFLLRNP were 
shown to have little effect on receptor activation [l 11. 
3.2. Synthesis and analysis of photoactivatable peptides 
Peptides were synthesized as their C-terminal amides 
by solid-phase synthesis using Boc chemistry and puri- 
fied by RP-HPLC. Boc-p-azidophenylalanine was syn- 
thesized and substituted for either Phe2 or Leu3. Biotin 
was incorporated as a marker for purification and for 
identification of crosslinking sites. The coupling effi- 
ciency was > 99.5% for each cycle, but the crude peptides 
were shown to contain multiple peaks by RP-HPLC. 
This may have been due to p-azidophenylalanine or bio- 
tin undergoing side reactions during HF cleavage. After 
RP-HPLC purification overall yields were 40% and 25% 
for AZO-1 and AZO-2, respectively. Analytical RP- 
HPLC showed that AZO-1 was 95% pure while AZO-2 
had a purity of approximately 86% (data not shown). 
Both peptides were therefore re-purified by RP-HPLC 
and only the major components were tested for biologi- 
cal activities. Both peptides were further subjected to 
amino acid composition analysis confirming the substi- 
tution of phenylalanine in AZO-1 and leucine in AZO-2, 
respectively (Table 2). The p-azidophenylalanine resi- 
dues resulted in a peak co-eluting with leucine upon 
\I 
-_c (SSA/AZO-1) PHOTOLYZED 
-D_ ESAIAZO-1 
- AZO-1 PHOTOLYZED 
- AZO-l 
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--t_ (BWAZO-2) PHOTOLYZED 
+ ESAIAZO-2 
+ AZO-2 PHOTOLYZED 
-o_ AZO-2 
- WA 
RECIPROCAL DILUTION OF STREPTAVIDIN-PEROXIDASE 
Fig. 2. Evaluation of photocrosslinking between AZO-I (A) and AZO-2 
(B) and BSA by ELISA (see section 2 for details). Filled-in squares 
show photocrosslinking between the peptides and BSA as detected by 
streptavidin-peroxidase. The other traces are controls where either irra- 
diation was omitted (open squares) or where the peptides (irradiated 
or not) and BSA were coated onto the ELISA plates individually. 
separation of the PTC amino acid derivatives, thus ap- 
parently augmenting the amount of leucine in each pep- 
tide. Structural analysis by automated N-terminal se- 
quencing proved to be unsuitable, most likely due to the 
presence of the reactive p-azido group close to the pep- 
tides’ N-termini which prevented Edman degradation 
from progressing beyond this point. 
Electrospray mass spectrometry (ESMS) was thus em- 
ployed to confirm the structure of the peptides and most 
importantly to assure that both the p-azidophenylalanine 
and the biotin modifications had been correctly incorpo- 
rated. Surprisingly, both spectra showed that the major 
products had molecular masses which were approxi- 
mately 27 Da lower than expected (Fig. 1). Fast atom 
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bombardment mass spectrometry (FAB-MS) yielded 
similar results with mass differences of about 26 Da be- 
tween the expected and measured values (data not 
shown). In view of the lability and reactivity of the azido 
group we assumed that N, had been eliminated during 
mass measurement, either due to the elevated tempera- 
ture of the drying gas in ESMS (70°C) or to reaction with 
the FAB matrix (thioglycerol) transforming p-azido- 
phenylalanine into p-aminophenylalanine (dm = 26.0 
Da). To ensure that both peptides contained photoacti- 
vatable azido groups they were photoactivated in the 
presence of BSA (see below). 
3.3. Photolabelling 
To evaluate the ability of the azido-peptides to co- 
valently link BSA upon photolysis at 300 and 350 nm, 
BSA was irradiated for 30 min at 4°C in the presence of 
a 9-fold molar excess of either AZO-1 or AZO-2. Indi- 
vidual peptides (photolyzed or native), peptide/BSA mix- 
tures (photolyzed or non-photolyzed) were coated onto 
microtiter plate wells. ELISAs showed that biotin was 
detected by a streptavidin-peroxidase conjugate in the 
wells containing either AZO-1 or AZO-2 photolyzed 
with BSA (Fig. 2). The other wells were negative due to 
non-crosslinked peptides binding only weakly to the mi- 
crotiter plate. These results confirmed the presence of 
photoactivatable azido groups and supported the hy- 
pothesis that the azido groups had been converted into 
amino groups during mass spectrometric analysis. 
Table 2 
Amino acid composition analysis of photoactivatable biotinylated pep- 
tides AZO-I and AZO-2” 
Amino acid Expected Measured Expected Measured 
AZO-I AZO-1 AZO-2 AZO-2 
D+N 1 1.2 1 1.2 
E+Q 0 0 0 0 
S 1 1.1 1 0.9 
G 2 1.7 2 1.7 
H 0 0 0 0 
R 1 0.8 I 0.9 
T 0 0 0 0 
A 0 0 0 0 
P 1 I.1 1 1.3 
Y 0 0 0 0 
V 0 0 0 0 
I 0 0 0 0 
Lb 2 3.4 1 2.1 
F’ 0 0 1 1.1 
Kd 2 1.9 2 2.1 
a All measured values are averaged over four determinations. Trp, Met 
and Cys were not included in these analyses. 
“A derivative of p-azidophenylalanine gave rise to a peak that co-eluted 
with PTC-leucine thus increasing the apparent amount of leucine. 
“p-Azidophenylalanine was not included in the expected amino acid 
composition since it will not give phenylalanine upon acid hydrolysis. 
’ Biotinylated lysine was included in the expected amino acid composi- 
tion since the biotin moiety was linked to the lysine side chain via an 
amide linkage which will most likely be hydrolyzed in 6 N HCI. 
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Fig. 3. Effects of photoactivatable peptides on intracellular Ca” mobilization in HEL cells. Each peptide was tested at a concentration of 10 PM 
(the arrow indicates the time when peptides were added) with the natural agonist SFLLRNP (a) and AZO-2 (p-azidophenylalanine in position 3) 
(b) giving identical results while AZO-1 @-azidophenylalanine in position 2) (c) showing a markedly reduced response. Intracellular Ca” concentra- 
tion is shown as the fluoresecence emission of the Ca’Vfura2 complex at 510 nm, calculated as the ratio of emissions upon excitation at 340 and 380 
nm, respectively (see section 2 for details). 
3.4. Biological activity 
Functional activity of the photoactivatable peptides 
was evaluated by measuring the increase in intracellular 
Ca2’ concentration in HEL cells that had been preloaded 
with the fluorescence indicator fura-2/acetoxymethyl 
ester. It had previously been shown that activation of the 
thrombin receptor resulted in an increase in the intracel- 
lular Ca2’ level as part of the signal transduction path- 
way [IS]. Incubation of preloaded HEL cells with either 
the natural agonist SFLLRNP or with AZO-2 @-azido- 
phenylalanine in position 3, see Fig. 1) at 10 ,uM resulted 
in an identical increase in fluorescence at 5 10 nm indicat- 
ing that both peptides were equally capable of increasing 
intracellular Ca2’ concentrations at this concentration 
(Fig. 3). However, incubation with 10 ,uM AZO-1 
(p-azidophenylalanine at position 2, see Fig. 1) had al- 
most no influence on the level of intracellular Ca”, indi- 
cating that AZO-1 was a much less potent receptor ag- 
onist than AZO-2 (Fig. 3). 
4. Discussion 
Photoaffinity labelling of proteins, including G-pro- 
tein coupled receptors, has provided detailed insights 
into the binding sites for substrate analogs, receptor ag- 
onists and antagonists, as well as into the structural tran- 
sitions related to activation and signal transduction [181. 
This approach has to be considered as being complemen- 
tary to site-directed mutagenesis in locating amino acid 
residues that are critical for ligand binding and signal 
transduction. Both photoaffinity labelling and site-di- 
rected mutagenesis can provide insights into the architec- 
ture of the ligand binding site and help to design new 
peptidic or non-peptidic agonists and antagonists in con- 
junction with molecular modelling techniques [19]. 
The present work describes the synthesis and func- 
tional analysis of modified photoactivatable peptides de- 
rived from the human thrombin receptor agonist peptide 
SFLLRNP. The results show that Leu3 can be substi- 
tuted with the photoactivatable amino acid derivative 
p-azidophenylalanine with little effect on biological ac- 
tivity (AZO-2 peptide) while p-azidophenylalanine in po- 
sition 2 reduces activity significantly (AZO-1 peptide). 
These results are in agreement with earlier work where 
the structure of the amino acid in position 2 was shown 
to be of critical importance for agonist activity while 
position 3 was more forgiving towards structural 
changes ([l l] and Table 1). Peptide AZO-2, an agonist 
of the human thrombin receptor containing a photoacti- 
vatable azido group located between two amino acid 
residues (positions 2 and 4, see Table 1) which have been 
shown to be crucial for receptor activation, is therefore 
an interesting candidate for photoaffinity labelling stud- 
ies and may allow a more detailed view of the receptor 
ligand binding site which is so far unknown. Further- 
more, incorporation of biotin into AZO-2 should allow 
sensitive detection of the labelled receptor and may in the 
future help in its isolation and the study of the crosslink- 
ing sites. 
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